Showing results (831-840 of 1,163) with videos related to
Sort By:
Pageof 117
Journal of the American College of Cardiology|November 17, 2024
Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary StudyKershaw V Patel, Zainali Chunawala, Subodh Verma, et al.Circulation. Heart Failure|July 7, 2023
Background Medical Therapy and Clinical Outcomes From the VICTORIA TrialJustin A Ezekowitz, Ciaran J McMullan, Cynthia M Westerhout, et al.Journal of Cardiac Failure|April 8, 2026
Performance of the HFpEF-ABA, H<sub>2</sub>FPEF, and HFA-PEFF Algorithms in HFpEF: A Participant-Level Pooled Analysis of Randomized Clinical TrialsJohn W Ostrominski, Fernando A Lara Lince, Brian L Claggett, et al.JAMA Cardiology|April 25, 2019
Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF TrialBarry Greenberg, James D Neaton, Stefan D Anker, et al.Journal of Cardiac Failure|August 30, 2025
Assessing Benefit in Heart Failure Patients with Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk StratificationChristopher M O'Connor, Sarah Rathwell, Devan V Mehrotra, et al.Journal of the American College of Cardiology|August 30, 2022
Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart FailureMuthiah Vaduganathan, Brian L Claggett, Pardeep Jhund, et al.Diabetes Care|July 12, 2019
Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection FractionJasper Tromp, Shir Lynn Lim, Wan Ting Tay, et al.European Heart Journal|April 8, 2022
Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fractionJasper Tromp, Wouter Ouwerkerk, Tiew-Hwa K Teng, et al.European Journal of Heart Failure|June 9, 2025
Application of a transthyretin amyloid cardiomyopathy score to heart failure with mildly reduced or preserved ejection fractionRiccardo M Inciardi, Muthiah Vaduganathan, Brian Claggett, et al.European Journal of Heart Failure|April 13, 2025
Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trialJawad H Butt, Pardeep S Jhund, Alasdair D Henderson, et al.Pageof 117